Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Congress drug development Drug prices

	Profile	Recent Articles on Subject
1	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: New obesity definition sidelines BMI to focus on health - 4 days ago Daily briefing: What causes obesity? Contentious topic gets an authoritative analysis - 5 months ago
2	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Form Health Unveils New Program to Prevent the Transition from Overweight to Obesity - 6 days ago Report: A “Multifaceted Approach” Is Needed To Tackle the Obesity Epidemic - 5 months ago
3	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: The Persistent Association Between Obesity and Breast Cancer Outcomes - about 1 month ago Research Links Poor Sleep With Anxiety, Depression in Older Individuals With Obesity - over 1 year ago Study Finds Obesity Remission Rates Are Lower Than Overweight Remission Rates in Children - over 1 year ago
4	The Conversation Science Alert Science news. Official account. Australia science news	Scientists Predict 80% of American Adults Will Be Overweight or Obese by 2050 - about 2 months ago Does Obesity Protect Against Dementia, or Increase Risk? - 9 months ago
5	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Amgen drug leads to substantial weight loss in study, but questions remain about competitiveness - about 2 months ago STAT+: Novo Nordisk reports continued growth in obesity drug sales - 3 months ago STAT+: A second Roche obesity drug shows promise in early studies - 6 months ago STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success - 10 months ago STAT+: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH - 11 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - about 1 year ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - about 1 year ago
6	Kristen Monaco MedPage Today	75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data? - 2 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 6 months ago Adolescent Obesity Tied to Parents' BMI at the Same Age - 7 months ago USPSTF Recommends Behavioral Interventions for Kids With High BMI - 7 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 9 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 11 months ago Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes - about 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - about 1 year ago Year in Review: Obesity - about 1 year ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - about 1 year ago Over One-Third of Adults in 22 States Have Obesity, CDC Says - over 1 year ago
7	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs - 2 months ago Obesity Medication Type, Insurance Carrier Linked to Treatment Persistence - over 1 year ago Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study - over 1 year ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Novo Nordisk reports continued growth in obesity drug sales - 3 months ago More than 1 billion people have obesity, including 159 million young people, study estimates - 11 months ago STAT+: Liver disease MASH is next target for obesity drugs in development - 11 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - about 1 year ago Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch - about 1 year ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - about 1 year ago AMA urges coverage of obesity treatments as payers balk at costs - about 1 year ago STAT+: Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies - over 1 year ago
9	Jennifer Henderson MedPage Today Enterprise & Investigative Writer. Works with MedPage Today. Enterprise writinginvestigative journalismhealthcare	Obesity May Raise Risk of Long COVID in Youth - 3 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark - 3 months ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 6 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 11 months ago STAT+: Pharmalittle: People with obesity harmed by exclusion from studies; Teva sues Colorado over ‘unconstitutional’ program - over 1 year ago

Journalists covering obesity